Continuity of Operations planning information for the College of Education: Click here


Recent Changes to Grant Policies

National Science Foundation (NSF)

January 29, 2018: NSF PAPPG 18-1 effective for proposals submitted on or after Jan. 28 (FastLane submissions).

  • Project Description must now contain a separate section specifically identified as "Intellectual Merit" in addition to the separate sections on "Broader Impacts" and "Results from Prior NSF Support.
  • Results from Prior NSF Support time period is clarified: "The purpose of this section is to assist reviewers in assessing the quality of prior work conducted with prior or current NSF funding. If any PI or co-PI identified on the proposal has received prior NSF support including:
    • an award with an end date in the past five years; or
    • any current funding, including any no cost extensions,

Information on the award is required for each PI and co-PI, regardless of whether the support was directly related to the proposal or not.

  • Budget Justification page limit has been increased from 3 pages to 5 pages per justification; e.g., subaward budget justifications can also be 5 pages.

December 15, 2017: Collaborators and Other Affiliations Template FAQ (pdf)

April 24, 2017: Collaborators and Other Affiliations Template required.


National Institutes of Health (NIH)

March 7, 2018: Salary Cap update.

January 25, 2018: General Application Guide effective for proposals submitted on or after Jan. 25 (aka Forms E applications).

Important - Human Subject Research Changes at NIH Effective January 25, 2018

Planning to submit a proposal to NIH in 2018?

Please read through the information below and contact the Grants and Contracts office with any questions.

15-minute video presented by NIH on Human Subjects & Clinical Trials changes.

If you are applying for research that involves human subjects, these changes may affect how you:

  •  select the right NIH funding opportunity announcement
  •  write the research strategy and human subjects sections of your application
  • comply with appropriate policies and regulations

First, familiarize yourself with the new PHS Human Subject and Clinical Trial Information form (pdf example with annotations). For application due dates of January 25, 2018, and beyond, you will be required to use an updated application forms package (FORMS-E), which includes the new human subject and clinical trial form. This form requests human subject and clinical trials information at the study level using discrete form fields.

Some NIH Institutes no longer accept parent announcements for clinical trials and will announce their own solicitations. Be sure to check the announcement for your target institute.

It is very important in the early proposal process to identity whether or not you need to respond to a Clinical Trial or non-Clinical Trial Funding Opportunity Announcement (FOA) and that you begin the application with the correct funding announcement.

Second, take a moment to answer these four questions about your current or proposed research:

1)    Does the study involve human participants?

2)    Are the participants prospectively assigned to an intervention?

3)    Is the study designed to evaluate the effect of the intervention on the participants?

4)    Is the effect that will be evaluated a health-related biomedical or behavioral outcome?

If the answer to all four questions is Yes, then your proposed research meets the NIH definition of a clinical trial. The definition encompasses a wide range of trial types: mechanistic, exploratory/developmental, pilot/feasibility, behavioral, and more.

Need more help determining whether your study would be considered by NIH to be a clinical trial? After reading information on the NIH website and walking through the decision tree, contact your NIH program official or the scientific point of contact listed on the funding opportunity announcement to which you are applying.

The Penn State IRB office is always willing to assist in your determination and would prefer to be involved early in the submission planning process, especially if your proposal includes a clinical trial.

Third, familiarize yourself with NIH policy changes related to enhancing stewardship of clinical trials.

NIH has made a number of policy changes to improve the stewardship of clinical trials across the life cycle of the trial. We encourage you to familiarize yourself with all that is changing, including:

  • The requirement to apply to an FOA that specifically allows for the submission of clinical trial applications for due dates beginning January 25, 2018.
  • Good Clinical Practice training expectations for NIH staff, grantees, and contractors that went into effect January 2017.
  • Updated peer review criteria that will be included in FOAs for clinical trial applications and solicitations for due dates on/after January 25, 2018.
  • New Human Subject Information form requirements for clinical trials that will be included in updated application forms (FORMS-E) for due dates on/after January 25, 2018, and contract solicitations published as of January 25, 2018.
  • Use of a single IRB for non-exempt, multi-site clinical trials for application due dates on/after January 25, 2018.
  • Expanded registration and reporting to include all NIH supported clinical trials.

May 31, 2017: Reminder: Authentication of Key Biological and/or Chemical Resources

May 30, 2017: Policy on Post-Submission Materials

March 24, 2017: Citing interim research products in applications, proposals and reports

March 2, 2017: Update and Clarification: NIH Continuous Submission Policy

January 25, 2017: New Appendix Policy

January 4, 2017: Updated Font Guidelines (Among the changes: black font is no longer required.)